Global Pet Pharmaceuticals Market

Pet Pharmaceuticals Comprehensive Study by Type (Pain Medications, Anesthetics, Heartworm Preventatives, Antibiotics, Chemotherapy drugs), Application (Treatment, Prevention), Distribution Chanel (Online, Offline) Players and Region - Global Market Outlook to 2026

Pet Pharmaceuticals Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Pet Pharmaceuticals Market?

The pet pharmaceuticals are the medicines used for health maintenance, prevention and cure of diseases of the pets. There is an increase in the population of the pets increasing the demand of pet pharmaceuticals. The pets are facing health problems due to their lifestyle. Hence the pet pharmaceutical market increasing with increasing demand from the market. Pet pharmaceuticals come in a variety of forms allow the owner or veterinarian to administer the needed medications including pills, liquids, injections, powders, feed additives etc.

The market study is being classified by Type (Pain Medications, Anesthetics, Heartworm Preventatives, Antibiotics and Chemotherapy drugs), by Application (Treatment and Prevention) and major geographies with country level break-up.

Zoetis (United States), Merck Animal Health (United States), Merial (France), Elanco (United States), Bayer (Germany), Boehringer Ingelheim (Germany), Novartis (Germany), Virbac Group (United States), Ceva (France) and Vetoquinol (France) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Eli Lilly and Company (United States), Aratana Therapeutics, Inc. (United States), Dechra Pharmaceuticals plc (United Kingdom) and Perrigo Company plc (Ireland).

Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Pet Pharmaceuticals market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Pet Pharmaceuticals market by Type, Application and Region.

On the basis of geography, the market of Pet Pharmaceuticals has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Growing Health Concern Related To Pets
  • Increased Zoonotic and Food Borne Diseases
  • Increased Pet Adoption
  • Growing Animal Healthcare Expenditure

Market Trend
  • Growth of the Generic and OTC Drugs for Animal Care

Restraints
  • Fever New Chemical Entity Approvals

Opportunities
  • Continuous Demand for Various Pet Animals’ Healthcare Products
  • Rising Government Initiatives to Promote Veterinary Products

Challenges
  • Low Productivity of Research Developing Competition


Market Leaders and some development strategies
On 20th August 2019, Elanco Animal Health Incorporated announced the agreement with Bayer AG to acquire its animal health business.
On 06/06/2018, Regeneron Pharmaceuticals, Inc. and Zoetis Inc. announced a five-year collaboration to research the use of Regeneron’s monoclonal antibody therapeutics in animals and discover new veterinary treatments.
Center for Veterinary Medicine (CVM) is the FDA center responsible for overseeing the animal and veterinary program in the United States.

Key Target Audience
Pet Pharmaceutical Manufacturers, Raw Material Suppliers/ Buyers, Distributors, Research Institutes, Government Body & Associations and End-user

Report Objectives / Segmentation Covered

By Type
  • Pain Medications
  • Anesthetics
  • Heartworm Preventatives
  • Antibiotics
  • Chemotherapy drugs
By Application
  • Treatment
  • Prevention
By Distribution Chanel
  • Online
  • Offline

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Health Concern Related To Pets
      • 3.2.2. Increased Zoonotic and Food Borne Diseases
      • 3.2.3. Increased Pet Adoption
      • 3.2.4. Growing Animal Healthcare Expenditure
    • 3.3. Market Challenges
      • 3.3.1. Low Productivity of Research Developing Competition
    • 3.4. Market Trends
      • 3.4.1. Growth of the Generic and OTC Drugs for Animal Care
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pet Pharmaceuticals, by Type, Application, Distribution Chanel and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Pet Pharmaceuticals (Value)
      • 5.2.1. Global Pet Pharmaceuticals by: Type (Value)
        • 5.2.1.1. Pain Medications
        • 5.2.1.2. Anesthetics
        • 5.2.1.3. Heartworm Preventatives
        • 5.2.1.4. Antibiotics
        • 5.2.1.5. Chemotherapy drugs
      • 5.2.2. Global Pet Pharmaceuticals by: Application (Value)
        • 5.2.2.1. Treatment
        • 5.2.2.2. Prevention
      • 5.2.3. Global Pet Pharmaceuticals by: Distribution Chanel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Offline
      • 5.2.4. Global Pet Pharmaceuticals Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Pet Pharmaceuticals (Volume)
      • 5.3.1. Global Pet Pharmaceuticals by: Type (Volume)
        • 5.3.1.1. Pain Medications
        • 5.3.1.2. Anesthetics
        • 5.3.1.3. Heartworm Preventatives
        • 5.3.1.4. Antibiotics
        • 5.3.1.5. Chemotherapy drugs
      • 5.3.2. Global Pet Pharmaceuticals by: Application (Volume)
        • 5.3.2.1. Treatment
        • 5.3.2.2. Prevention
      • 5.3.3. Global Pet Pharmaceuticals by: Distribution Chanel (Volume)
        • 5.3.3.1. Online
        • 5.3.3.2. Offline
      • 5.3.4. Global Pet Pharmaceuticals Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Pet Pharmaceuticals (Price)
      • 5.4.1. Global Pet Pharmaceuticals by: Type (Price)
  • 6. Pet Pharmaceuticals: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Zoetis (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck Animal Health (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merial (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Elanco (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bayer (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Boehringer Ingelheim (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Novartis (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Virbac Group (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Ceva (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Vetoquinol (France)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Pet Pharmaceuticals Sale, by Type, Application, Distribution Chanel and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Pet Pharmaceuticals (Value)
      • 7.2.1. Global Pet Pharmaceuticals by: Type (Value)
        • 7.2.1.1. Pain Medications
        • 7.2.1.2. Anesthetics
        • 7.2.1.3. Heartworm Preventatives
        • 7.2.1.4. Antibiotics
        • 7.2.1.5. Chemotherapy drugs
      • 7.2.2. Global Pet Pharmaceuticals by: Application (Value)
        • 7.2.2.1. Treatment
        • 7.2.2.2. Prevention
      • 7.2.3. Global Pet Pharmaceuticals by: Distribution Chanel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Offline
      • 7.2.4. Global Pet Pharmaceuticals Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Pet Pharmaceuticals (Volume)
      • 7.3.1. Global Pet Pharmaceuticals by: Type (Volume)
        • 7.3.1.1. Pain Medications
        • 7.3.1.2. Anesthetics
        • 7.3.1.3. Heartworm Preventatives
        • 7.3.1.4. Antibiotics
        • 7.3.1.5. Chemotherapy drugs
      • 7.3.2. Global Pet Pharmaceuticals by: Application (Volume)
        • 7.3.2.1. Treatment
        • 7.3.2.2. Prevention
      • 7.3.3. Global Pet Pharmaceuticals by: Distribution Chanel (Volume)
        • 7.3.3.1. Online
        • 7.3.3.2. Offline
      • 7.3.4. Global Pet Pharmaceuticals Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Pet Pharmaceuticals (Price)
      • 7.4.1. Global Pet Pharmaceuticals by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pet Pharmaceuticals: by Type(USD Million)
  • Table 2. Pet Pharmaceuticals Pain Medications , by Region USD Million (2015-2020)
  • Table 3. Pet Pharmaceuticals Anesthetics , by Region USD Million (2015-2020)
  • Table 4. Pet Pharmaceuticals Heartworm Preventatives , by Region USD Million (2015-2020)
  • Table 5. Pet Pharmaceuticals Antibiotics , by Region USD Million (2015-2020)
  • Table 6. Pet Pharmaceuticals Chemotherapy drugs , by Region USD Million (2015-2020)
  • Table 7. Pet Pharmaceuticals: by Application(USD Million)
  • Table 8. Pet Pharmaceuticals Treatment , by Region USD Million (2015-2020)
  • Table 9. Pet Pharmaceuticals Prevention , by Region USD Million (2015-2020)
  • Table 10. Pet Pharmaceuticals: by Distribution Chanel(USD Million)
  • Table 11. Pet Pharmaceuticals Online , by Region USD Million (2015-2020)
  • Table 12. Pet Pharmaceuticals Offline , by Region USD Million (2015-2020)
  • Table 13. South America Pet Pharmaceuticals, by Country USD Million (2015-2020)
  • Table 14. South America Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 15. South America Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 16. South America Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 17. Brazil Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 18. Brazil Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 19. Brazil Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 20. Argentina Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 21. Argentina Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 22. Argentina Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 23. Rest of South America Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 24. Rest of South America Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 25. Rest of South America Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 26. Asia Pacific Pet Pharmaceuticals, by Country USD Million (2015-2020)
  • Table 27. Asia Pacific Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 28. Asia Pacific Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 29. Asia Pacific Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 30. China Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 31. China Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 32. China Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 33. Japan Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 34. Japan Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 35. Japan Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 36. India Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 37. India Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 38. India Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 39. South Korea Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 40. South Korea Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 41. South Korea Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 42. Taiwan Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 43. Taiwan Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 44. Taiwan Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 45. Australia Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 46. Australia Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 47. Australia Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 51. Europe Pet Pharmaceuticals, by Country USD Million (2015-2020)
  • Table 52. Europe Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 53. Europe Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 54. Europe Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 55. Germany Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 56. Germany Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 57. Germany Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 58. France Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 59. France Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 60. France Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 61. Italy Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 62. Italy Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 63. Italy Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 64. United Kingdom Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 65. United Kingdom Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 66. United Kingdom Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 67. Netherlands Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 68. Netherlands Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 69. Netherlands Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 70. Rest of Europe Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 71. Rest of Europe Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 72. Rest of Europe Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 73. MEA Pet Pharmaceuticals, by Country USD Million (2015-2020)
  • Table 74. MEA Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 75. MEA Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 76. MEA Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 77. Middle East Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 78. Middle East Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 79. Middle East Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 80. Africa Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 81. Africa Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 82. Africa Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 83. North America Pet Pharmaceuticals, by Country USD Million (2015-2020)
  • Table 84. North America Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 85. North America Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 86. North America Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 87. United States Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 88. United States Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 89. United States Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 90. Canada Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 91. Canada Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 92. Canada Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 93. Mexico Pet Pharmaceuticals, by Type USD Million (2015-2020)
  • Table 94. Mexico Pet Pharmaceuticals, by Application USD Million (2015-2020)
  • Table 95. Mexico Pet Pharmaceuticals, by Distribution Chanel USD Million (2015-2020)
  • Table 96. Pet Pharmaceuticals Sales: by Type(K Units)
  • Table 97. Pet Pharmaceuticals Sales Pain Medications , by Region K Units (2015-2020)
  • Table 98. Pet Pharmaceuticals Sales Anesthetics , by Region K Units (2015-2020)
  • Table 99. Pet Pharmaceuticals Sales Heartworm Preventatives , by Region K Units (2015-2020)
  • Table 100. Pet Pharmaceuticals Sales Antibiotics , by Region K Units (2015-2020)
  • Table 101. Pet Pharmaceuticals Sales Chemotherapy drugs , by Region K Units (2015-2020)
  • Table 102. Pet Pharmaceuticals Sales: by Application(K Units)
  • Table 103. Pet Pharmaceuticals Sales Treatment , by Region K Units (2015-2020)
  • Table 104. Pet Pharmaceuticals Sales Prevention , by Region K Units (2015-2020)
  • Table 105. Pet Pharmaceuticals Sales: by Distribution Chanel(K Units)
  • Table 106. Pet Pharmaceuticals Sales Online , by Region K Units (2015-2020)
  • Table 107. Pet Pharmaceuticals Sales Offline , by Region K Units (2015-2020)
  • Table 108. South America Pet Pharmaceuticals Sales, by Country K Units (2015-2020)
  • Table 109. South America Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 110. South America Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 111. South America Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 112. Brazil Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 113. Brazil Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 114. Brazil Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 115. Argentina Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 116. Argentina Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 117. Argentina Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 118. Rest of South America Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 119. Rest of South America Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 120. Rest of South America Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 121. Asia Pacific Pet Pharmaceuticals Sales, by Country K Units (2015-2020)
  • Table 122. Asia Pacific Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 123. Asia Pacific Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 124. Asia Pacific Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 125. China Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 126. China Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 127. China Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 128. Japan Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 129. Japan Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 130. Japan Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 131. India Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 132. India Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 133. India Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 134. South Korea Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 135. South Korea Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 136. South Korea Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 137. Taiwan Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 138. Taiwan Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 139. Taiwan Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 140. Australia Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 141. Australia Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 142. Australia Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 143. Rest of Asia-Pacific Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 144. Rest of Asia-Pacific Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 145. Rest of Asia-Pacific Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 146. Europe Pet Pharmaceuticals Sales, by Country K Units (2015-2020)
  • Table 147. Europe Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 148. Europe Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 149. Europe Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 150. Germany Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 151. Germany Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 152. Germany Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 153. France Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 154. France Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 155. France Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 156. Italy Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 157. Italy Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 158. Italy Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 159. United Kingdom Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 160. United Kingdom Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 161. United Kingdom Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 162. Netherlands Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 163. Netherlands Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 164. Netherlands Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 165. Rest of Europe Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 166. Rest of Europe Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 167. Rest of Europe Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 168. MEA Pet Pharmaceuticals Sales, by Country K Units (2015-2020)
  • Table 169. MEA Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 170. MEA Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 171. MEA Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 172. Middle East Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 173. Middle East Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 174. Middle East Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 175. Africa Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 176. Africa Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 177. Africa Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 178. North America Pet Pharmaceuticals Sales, by Country K Units (2015-2020)
  • Table 179. North America Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 180. North America Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 181. North America Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 182. United States Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 183. United States Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 184. United States Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 185. Canada Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 186. Canada Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 187. Canada Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 188. Mexico Pet Pharmaceuticals Sales, by Type K Units (2015-2020)
  • Table 189. Mexico Pet Pharmaceuticals Sales, by Application K Units (2015-2020)
  • Table 190. Mexico Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2015-2020)
  • Table 191. Pet Pharmaceuticals: by Type(USD/Units)
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Pet Pharmaceuticals: by Type(USD Million)
  • Table 203. Pet Pharmaceuticals Pain Medications , by Region USD Million (2021-2026)
  • Table 204. Pet Pharmaceuticals Anesthetics , by Region USD Million (2021-2026)
  • Table 205. Pet Pharmaceuticals Heartworm Preventatives , by Region USD Million (2021-2026)
  • Table 206. Pet Pharmaceuticals Antibiotics , by Region USD Million (2021-2026)
  • Table 207. Pet Pharmaceuticals Chemotherapy drugs , by Region USD Million (2021-2026)
  • Table 208. Pet Pharmaceuticals: by Application(USD Million)
  • Table 209. Pet Pharmaceuticals Treatment , by Region USD Million (2021-2026)
  • Table 210. Pet Pharmaceuticals Prevention , by Region USD Million (2021-2026)
  • Table 211. Pet Pharmaceuticals: by Distribution Chanel(USD Million)
  • Table 212. Pet Pharmaceuticals Online , by Region USD Million (2021-2026)
  • Table 213. Pet Pharmaceuticals Offline , by Region USD Million (2021-2026)
  • Table 214. South America Pet Pharmaceuticals, by Country USD Million (2021-2026)
  • Table 215. South America Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 216. South America Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 217. South America Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 218. Brazil Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 219. Brazil Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 220. Brazil Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 221. Argentina Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 222. Argentina Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 223. Argentina Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 224. Rest of South America Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 225. Rest of South America Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 226. Rest of South America Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 227. Asia Pacific Pet Pharmaceuticals, by Country USD Million (2021-2026)
  • Table 228. Asia Pacific Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 229. Asia Pacific Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 230. Asia Pacific Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 231. China Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 232. China Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 233. China Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 234. Japan Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 235. Japan Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 236. Japan Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 237. India Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 238. India Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 239. India Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 240. South Korea Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 241. South Korea Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 242. South Korea Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 243. Taiwan Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 244. Taiwan Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 245. Taiwan Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 246. Australia Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 247. Australia Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 248. Australia Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 249. Rest of Asia-Pacific Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 250. Rest of Asia-Pacific Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 251. Rest of Asia-Pacific Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 252. Europe Pet Pharmaceuticals, by Country USD Million (2021-2026)
  • Table 253. Europe Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 254. Europe Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 255. Europe Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 256. Germany Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 257. Germany Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 258. Germany Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 259. France Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 260. France Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 261. France Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 262. Italy Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 263. Italy Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 264. Italy Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 265. United Kingdom Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 266. United Kingdom Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 267. United Kingdom Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 268. Netherlands Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 269. Netherlands Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 270. Netherlands Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 271. Rest of Europe Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 272. Rest of Europe Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 273. Rest of Europe Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 274. MEA Pet Pharmaceuticals, by Country USD Million (2021-2026)
  • Table 275. MEA Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 276. MEA Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 277. MEA Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 278. Middle East Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 279. Middle East Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 280. Middle East Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 281. Africa Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 282. Africa Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 283. Africa Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 284. North America Pet Pharmaceuticals, by Country USD Million (2021-2026)
  • Table 285. North America Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 286. North America Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 287. North America Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 288. United States Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 289. United States Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 290. United States Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 291. Canada Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 292. Canada Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 293. Canada Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 294. Mexico Pet Pharmaceuticals, by Type USD Million (2021-2026)
  • Table 295. Mexico Pet Pharmaceuticals, by Application USD Million (2021-2026)
  • Table 296. Mexico Pet Pharmaceuticals, by Distribution Chanel USD Million (2021-2026)
  • Table 297. Pet Pharmaceuticals Sales: by Type(K Units)
  • Table 298. Pet Pharmaceuticals Sales Pain Medications , by Region K Units (2021-2026)
  • Table 299. Pet Pharmaceuticals Sales Anesthetics , by Region K Units (2021-2026)
  • Table 300. Pet Pharmaceuticals Sales Heartworm Preventatives , by Region K Units (2021-2026)
  • Table 301. Pet Pharmaceuticals Sales Antibiotics , by Region K Units (2021-2026)
  • Table 302. Pet Pharmaceuticals Sales Chemotherapy drugs , by Region K Units (2021-2026)
  • Table 303. Pet Pharmaceuticals Sales: by Application(K Units)
  • Table 304. Pet Pharmaceuticals Sales Treatment , by Region K Units (2021-2026)
  • Table 305. Pet Pharmaceuticals Sales Prevention , by Region K Units (2021-2026)
  • Table 306. Pet Pharmaceuticals Sales: by Distribution Chanel(K Units)
  • Table 307. Pet Pharmaceuticals Sales Online , by Region K Units (2021-2026)
  • Table 308. Pet Pharmaceuticals Sales Offline , by Region K Units (2021-2026)
  • Table 309. South America Pet Pharmaceuticals Sales, by Country K Units (2021-2026)
  • Table 310. South America Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 311. South America Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 312. South America Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 313. Brazil Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 314. Brazil Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 315. Brazil Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 316. Argentina Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 317. Argentina Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 318. Argentina Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 319. Rest of South America Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 320. Rest of South America Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 321. Rest of South America Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 322. Asia Pacific Pet Pharmaceuticals Sales, by Country K Units (2021-2026)
  • Table 323. Asia Pacific Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 324. Asia Pacific Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 325. Asia Pacific Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 326. China Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 327. China Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 328. China Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 329. Japan Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 330. Japan Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 331. Japan Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 332. India Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 333. India Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 334. India Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 335. South Korea Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 336. South Korea Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 337. South Korea Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 338. Taiwan Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 339. Taiwan Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 340. Taiwan Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 341. Australia Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 342. Australia Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 343. Australia Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 344. Rest of Asia-Pacific Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 345. Rest of Asia-Pacific Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 346. Rest of Asia-Pacific Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 347. Europe Pet Pharmaceuticals Sales, by Country K Units (2021-2026)
  • Table 348. Europe Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 349. Europe Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 350. Europe Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 351. Germany Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 352. Germany Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 353. Germany Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 354. France Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 355. France Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 356. France Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 357. Italy Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 358. Italy Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 359. Italy Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 360. United Kingdom Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 361. United Kingdom Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 362. United Kingdom Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 363. Netherlands Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 364. Netherlands Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 365. Netherlands Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 366. Rest of Europe Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 367. Rest of Europe Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 368. Rest of Europe Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 369. MEA Pet Pharmaceuticals Sales, by Country K Units (2021-2026)
  • Table 370. MEA Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 371. MEA Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 372. MEA Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 373. Middle East Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 374. Middle East Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 375. Middle East Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 376. Africa Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 377. Africa Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 378. Africa Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 379. North America Pet Pharmaceuticals Sales, by Country K Units (2021-2026)
  • Table 380. North America Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 381. North America Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 382. North America Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 383. United States Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 384. United States Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 385. United States Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 386. Canada Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 387. Canada Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 388. Canada Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 389. Mexico Pet Pharmaceuticals Sales, by Type K Units (2021-2026)
  • Table 390. Mexico Pet Pharmaceuticals Sales, by Application K Units (2021-2026)
  • Table 391. Mexico Pet Pharmaceuticals Sales, by Distribution Chanel K Units (2021-2026)
  • Table 392. Pet Pharmaceuticals: by Type(USD/Units)
  • Table 393. Research Programs/Design for This Report
  • Table 394. Key Data Information from Secondary Sources
  • Table 395. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pet Pharmaceuticals: by Type USD Million (2015-2020)
  • Figure 5. Global Pet Pharmaceuticals: by Application USD Million (2015-2020)
  • Figure 6. Global Pet Pharmaceuticals: by Distribution Chanel USD Million (2015-2020)
  • Figure 7. South America Pet Pharmaceuticals Share (%), by Country
  • Figure 8. Asia Pacific Pet Pharmaceuticals Share (%), by Country
  • Figure 9. Europe Pet Pharmaceuticals Share (%), by Country
  • Figure 10. MEA Pet Pharmaceuticals Share (%), by Country
  • Figure 11. North America Pet Pharmaceuticals Share (%), by Country
  • Figure 12. Global Pet Pharmaceuticals: by Type K Units (2015-2020)
  • Figure 13. Global Pet Pharmaceuticals: by Application K Units (2015-2020)
  • Figure 14. Global Pet Pharmaceuticals: by Distribution Chanel K Units (2015-2020)
  • Figure 15. South America Pet Pharmaceuticals Share (%), by Country
  • Figure 16. Asia Pacific Pet Pharmaceuticals Share (%), by Country
  • Figure 17. Europe Pet Pharmaceuticals Share (%), by Country
  • Figure 18. MEA Pet Pharmaceuticals Share (%), by Country
  • Figure 19. North America Pet Pharmaceuticals Share (%), by Country
  • Figure 20. Global Pet Pharmaceuticals: by Type USD/Units (2015-2020)
  • Figure 21. Global Pet Pharmaceuticals share by Players 2020 (%)
  • Figure 22. Global Pet Pharmaceuticals share by Players (Top 3) 2020(%)
  • Figure 23. Global Pet Pharmaceuticals share by Players (Top 5) 2020(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Zoetis (United States) Revenue, Net Income and Gross profit
  • Figure 26. Zoetis (United States) Revenue: by Geography 2020
  • Figure 27. Merck Animal Health (United States) Revenue, Net Income and Gross profit
  • Figure 28. Merck Animal Health (United States) Revenue: by Geography 2020
  • Figure 29. Merial (France) Revenue, Net Income and Gross profit
  • Figure 30. Merial (France) Revenue: by Geography 2020
  • Figure 31. Elanco (United States) Revenue, Net Income and Gross profit
  • Figure 32. Elanco (United States) Revenue: by Geography 2020
  • Figure 33. Bayer (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Bayer (Germany) Revenue: by Geography 2020
  • Figure 35. Boehringer Ingelheim (Germany) Revenue, Net Income and Gross profit
  • Figure 36. Boehringer Ingelheim (Germany) Revenue: by Geography 2020
  • Figure 37. Novartis (Germany) Revenue, Net Income and Gross profit
  • Figure 38. Novartis (Germany) Revenue: by Geography 2020
  • Figure 39. Virbac Group (United States) Revenue, Net Income and Gross profit
  • Figure 40. Virbac Group (United States) Revenue: by Geography 2020
  • Figure 41. Ceva (France) Revenue, Net Income and Gross profit
  • Figure 42. Ceva (France) Revenue: by Geography 2020
  • Figure 43. Vetoquinol (France) Revenue, Net Income and Gross profit
  • Figure 44. Vetoquinol (France) Revenue: by Geography 2020
  • Figure 45. Global Pet Pharmaceuticals: by Type USD Million (2021-2026)
  • Figure 46. Global Pet Pharmaceuticals: by Application USD Million (2021-2026)
  • Figure 47. Global Pet Pharmaceuticals: by Distribution Chanel USD Million (2021-2026)
  • Figure 48. South America Pet Pharmaceuticals Share (%), by Country
  • Figure 49. Asia Pacific Pet Pharmaceuticals Share (%), by Country
  • Figure 50. Europe Pet Pharmaceuticals Share (%), by Country
  • Figure 51. MEA Pet Pharmaceuticals Share (%), by Country
  • Figure 52. North America Pet Pharmaceuticals Share (%), by Country
  • Figure 53. Global Pet Pharmaceuticals: by Type K Units (2021-2026)
  • Figure 54. Global Pet Pharmaceuticals: by Application K Units (2021-2026)
  • Figure 55. Global Pet Pharmaceuticals: by Distribution Chanel K Units (2021-2026)
  • Figure 56. South America Pet Pharmaceuticals Share (%), by Country
  • Figure 57. Asia Pacific Pet Pharmaceuticals Share (%), by Country
  • Figure 58. Europe Pet Pharmaceuticals Share (%), by Country
  • Figure 59. MEA Pet Pharmaceuticals Share (%), by Country
  • Figure 60. North America Pet Pharmaceuticals Share (%), by Country
  • Figure 61. Global Pet Pharmaceuticals: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Zoetis (United States)
  • Merck Animal Health (United States)
  • Merial (France)
  • Elanco (United States)
  • Bayer (Germany)
  • Boehringer Ingelheim (Germany)
  • Novartis (Germany)
  • Virbac Group (United States)
  • Ceva (France)
  • Vetoquinol (France)
Additional players considered in the study are as follows:
Eli Lilly and Company (United States) , Aratana Therapeutics, Inc. (United States) , Dechra Pharmaceuticals plc (United Kingdom) , Perrigo Company plc (Ireland)
Select User Access Type

Key Highlights of Report


Sep 2021 232 Pages 92 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Pet Pharmaceuticals Market Quantitative research analysis
Global Pet Pharmaceuticals Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Growing Health Concern Related To Pets " is seen as one of major growth factors of Pet Pharmaceuticals Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
United States will lead Pet Pharmaceuticals Market in coming years.

Know More About Global Pet Pharmaceuticals Market Report?

Have a Query? Click Here

Other Related Reports

Ophthalmol Drug Comprehensive Study by Type (Antiseptics, Corticosteroids, Anit- Microbial, Fluoroquinolone Antibiotic, Others), Administration (Oral, Intravenous, Parenteral), Indication (Cataract, ...
$ 3450
Chromoendoscopy Agents Comprehensive Study by Type (Absorptive Agent, Contrast Agent, Reactive Agent), Application (Colorectal, Esophageal, Gastric), By End User (Ambulatory Surgical Center, Diagnost...
$ 3350
Crohn Disease Comprehensive Study by Application (Achieving remission (the absence of symptoms), Maintaining remission (prevention of flare-ups), Pediatric Disease), Drug Type (Anti-inflammatory drug...
$ 3750
Lemon Balm Extract Comprehensive Study by End Users (Food & Beverages Industry, Cosmetic Industry, Pharmaceutical Industry, Pesticides Industry, Others), Distribution Channel (Online Stores, Hypermar...
$ 3650
Biperiden Comprehensive Study by Application (Children, Adults), Route of Administration (Oral, Injection) Players and Region - Global Market Outlook to 2026
$ 3500
Food Pharmaceutical Peony Comprehensive Study by Type (Peony Root-Bark Extract, Peony Seed Oil, Peony Essence, Other), Application (Food Industry, Pharmaceutical Industry) Players and Region - Global...
$ 3500